| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/05/2004 | CA2706900A1 Process for modifying drug crystal formation |
| 08/05/2004 | CA2554012A1 Oral dosage formulation |
| 08/05/2004 | CA2514325A1 A composition material for transmucosal delivery |
| 08/05/2004 | CA2513729A1 Co-precipitated amorphous losartan and dosage forms comprising the same |
| 08/05/2004 | CA2513616A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | CA2513575A1 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/05/2004 | CA2513572A1 Treatment of benign prostatic hyperplasia |
| 08/05/2004 | CA2513418A1 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 08/05/2004 | CA2513331A1 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 08/05/2004 | CA2513320A1 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | CA2513006A1 Drug particles obtained by freezing onto a cold surface |
| 08/05/2004 | CA2512824A1 Improved oral delivery of peptides |
| 08/05/2004 | CA2512786A1 Methods and dosage forms with modified viscosity layers |
| 08/05/2004 | CA2509259A1 Sustained-release preparations and method for producing the same |
| 08/04/2004 | EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof |
| 08/04/2004 | EP1443057A1 Rapidly expanding starches with altered crystalline structure |
| 08/04/2004 | EP1442764A1 Medicament ejector with ejection port servicing |
| 08/04/2004 | EP1442760A2 Multireservoir implantable drug delivery pumps |
| 08/04/2004 | EP1442747A1 Superoxide dismutase and mimetics thereof |
| 08/04/2004 | EP1442746A1 Stable solid formulation of enalapril salt and process for preparation thereof |
| 08/04/2004 | EP1442745A1 Orally administrable opioid formulations having extended duration of effect |
| 08/04/2004 | EP1442066A1 Compositions comprising chitosan in the form of nano-sized fibres |
| 08/04/2004 | EP1442004A1 Alkyl(en)ylglycerinether carboxylic acids |
| 08/04/2004 | EP1441845A1 Method for the production of particles |
| 08/04/2004 | EP1441785A2 Improved method for generating an aerosol |
| 08/04/2004 | EP1441784A2 Medical device for delivering patches |
| 08/04/2004 | EP1441778A1 Laminated patient infusion device |
| 08/04/2004 | EP1441775A1 Self-adhesive matrix plaster containing an active ingredient and based on polyurethane gels |
| 08/04/2004 | EP1441770A1 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility |
| 08/04/2004 | EP1441769A1 Low concentration of peroxide for treating or preventing vaginal infections |
| 08/04/2004 | EP1441768A1 Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use |
| 08/04/2004 | EP1441767A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment |
| 08/04/2004 | EP1441763A2 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid |
| 08/04/2004 | EP1441762A1 Rsv gene expression vaccine |
| 08/04/2004 | EP1441755A2 Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases |
| 08/04/2004 | EP1441748A2 High-concentration protein formulations and method of manufacture |
| 08/04/2004 | EP1441741A1 Rehydrating formulation |
| 08/04/2004 | EP1441727A1 Depot formulations of iloperidone and a star polymer |
| 08/04/2004 | EP1441713A1 Modified release tamsulosin tablets |
| 08/04/2004 | EP1441709A1 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 08/04/2004 | EP1441707A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
| 08/04/2004 | EP1441706A2 Antimuscarinic aerosol |
| 08/04/2004 | EP1441705A1 Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs |
| 08/04/2004 | EP1441704A1 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 08/04/2004 | EP1441703A2 System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing |
| 08/04/2004 | EP1441702A2 Method for treating primary insomnia |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441700A1 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 08/04/2004 | EP1441699A2 Powder for nasal administration of drugs |
| 08/04/2004 | EP1441698A1 Flashmelt oral dosage formulation |
| 08/04/2004 | EP1441697A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 08/04/2004 | EP1441696A1 Method and composition for dry eye treatment |
| 08/04/2004 | EP1441695A2 Switchable surfaces |
| 08/04/2004 | EP1441694A1 Gastric raft composition |
| 08/04/2004 | EP1441682A1 Method to induce neovascular formation and tissue regeneration |
| 08/04/2004 | EP1441679A1 Implantable fluid delivery apparatuses and implantable electrode |
| 08/04/2004 | EP1441656A1 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/04/2004 | EP1441635A2 Sterile, breathable patch for treating wound pain |
| 08/04/2004 | EP1441602A1 Molecular press dehydration method for vegetative tissue using the solid phase of water soluble polymer substances as a dehydrating agent |
| 08/04/2004 | EP1441589A2 Stable liquid pharmaceutical formulation of igg antibodies |
| 08/04/2004 | EP1401275A4 Antiviral composition and treatment method |
| 08/04/2004 | EP1370148A4 Anticholesterolemic edible oil |
| 08/04/2004 | EP1337236B1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 08/04/2004 | EP1313772B1 New cross-linked derivatives of hyaluronic acid |
| 08/04/2004 | EP1296675B1 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 08/04/2004 | EP1294380B1 A method for treating septic shock |
| 08/04/2004 | EP1278511B1 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds |
| 08/04/2004 | EP1239833B1 Reconstitution of purified membrane proteins into preformed liposomes |
| 08/04/2004 | EP1237423B1 Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition |
| 08/04/2004 | EP1208143B1 Film coatings and film coating compositions based on polyvinyl alcohol |
| 08/04/2004 | EP1165140B1 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1077065B1 Controlled release formulations |
| 08/04/2004 | EP1027093B1 Apparatus for applying 5-aminolevulinic acid |
| 08/04/2004 | EP0959941B1 Electro-release systems |
| 08/04/2004 | EP0690671B1 Method and apparatus for encapsulation of biologically-active substances in cells |
| 08/04/2004 | CN2629696Y Hand medicinal ointment application device |
| 08/04/2004 | CN1518567A Linear block polymer |
| 08/04/2004 | CN1518479A Stabilization and terminal sterilization of phospholipid formulations |
| 08/04/2004 | CN1518462A Pharmaceutical formulation |
| 08/04/2004 | CN1518461A Medicinal compositions |
| 08/04/2004 | CN1518460A Composition comprising PDE-4 inhibitor and H1-receptor antagonist and use thereof for manufacture of medicament for treatment of respiratory diseases |
| 08/04/2004 | CN1518446A Repinotan kit |
| 08/04/2004 | CN1518443A Stable pharmaceutical composition of pravastatin |
| 08/04/2004 | CN1518442A Pharmaceutical compositions comprising cyclosporin |
| 08/04/2004 | CN1518441A Particles for inhalation having rapid release properties |
| 08/04/2004 | CN1518412A Chewing gum to control malodorous breath |
| 08/04/2004 | CN1517394A Water-solubility natural film and its proparation method |
| 08/04/2004 | CN1517380A Composition for using polywax with biological absorptivity and medical device |
| 08/04/2004 | CN1517364A Deletion type human interleukin 11 microvariant |
| 08/04/2004 | CN1517126A Drug compastion with thrombolysis, anti-inflammatory and cell protective function |
| 08/04/2004 | CN1517125A Recombination human granul ocyte-macrophage colong stimulating factor ges and its preparation method |
| 08/04/2004 | CN1517124A Chinese medicinal composition possessing antipyretic and its preparation method and quality control method |
| 08/04/2004 | CN1517113A Ointment for treating burn and scald and its preparation method |
| 08/04/2004 | CN1517103A Natural medicine 'keaite capsule' possessing triple effect for treating HIV/AIDS |
| 08/04/2004 | CN1517097A Bambbo leaf flavone freeze dried powser injection, its preparation method and application |
| 08/04/2004 | CN1517094A Monosialic acid tetrahexose ganglioside liposome complex preparation |
| 08/04/2004 | CN1517090A Animal use suspensoid injection or emulsion containing antibacterial medicine |
| 08/04/2004 | CN1160128C Antiviral formulations comprising propylene glycol and isopropyl alkanoic acid ester |